Native Staphylococcus epidermidis D-Lactic Dehydrogenase
9028-36-8
Yes
2026-11-16
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName Native Staphylococcus epidermidis D-Lactic Dehydrogenase Cat No NATE-0197 Description D-lactic dehydrogenase catalyzes the conversion of D-lactate into D-pyruvate while reducing NAD+ to NADH and H+. Abbr D-LDH, Native (Staphylococcus epidermidis) Alias D-LDH Source Staphylococcus epidermidis Applications D-Lactic Dehydrogenase can be used to generate inhibitors of angiotensin converting enzyme by catalyzing the production of the intermediate (R)-2-Hydroxy-4-phenylbutyric acid. D-Lactic dehydrogenase has been used in a study to assess mechanisms of active transport in isolated membrane vesicles. It has also been used in a study to investigate β-galactoside transport in bacterial membrane preparations. Form Lyophilized powder containing primarily dextran Enzyme Commission Number EC 1.1.1.28 Activity > 80 units/mg solid CAS No 9028-36-8 Unit Definition One unit will reduce 1.0 μmole of pyruvate to D-lactate per min at pH 7.0 at 25°C. Storage −20°C Synonyms EC 1.1.1.28, D-Lactic Dehydrogenase; 9028-36-8; lactic acid dehydrogenase; D-specific lactic dehydrogenase; D-(–)-lactate dehydrogenase (NAD); D-lactic acid dehydrogenase; D-lactic dehydrogenase; (R)-Lactate:NAD+ oxidoreductase; D−LDH category Enzymes and Coenzymes Drugs(c1513) cas_num 9028-36-8 Basic Info-
Product Name:
D-Lactate dehydrogenase
Other Name:D-Lactate dehydrogenase;Dehydrogenase,D-lactate;E.C. 1.1.1.28;D-Lactic dehydrogenase;D-(-)-Lactate dehydrogenase;D-Lactic acid dehydrogenase;NAD-dependent D-lactate dehydrogenase;D-(-)-Lactate dehydrogenase (NAD);D-Lactic dehydrogenase (NAD);D-Lactate dehydrogenase (NAD);(R)-Lactate dehydrogenase
CAS No.:9028-36-8
EC Number:232-829-0
HScode:35079090
Categories:
Characteristics-
Appearance:
yellow suspension
Storage Conditions:2-8°C
Hazard IdentificationClassification of the substance or mixture
Respiratory sensitization, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled
Precautionary statement(s) Prevention P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P284 [In case of inadequate ventilation] wear respiratory protection.
Response P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P342+P316 If experiencing respiratory symptoms: Get emergency medical help immediately.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product